Skip to main content
RGEN filings

Corporate insider profile

Olivier Loeillot Filing Activity

Latest reported as Chief Executive Officer of REPLIGEN CORP (RGEN).

Purchase filings
0
Reported companies
1
Net open-market value
-$536,480.00
Latest transaction
Apr 21, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 21, 2026REPLIGEN CORP (RGEN)Chief Executive OfficerSale3,832$140.00$536,480